raubasine has been researched along with dihydroergotamine in 3 studies
| Studies (raubasine) | Trials (raubasine) | Recent Studies (post-2010) (raubasine) | Studies (dihydroergotamine) | Trials (dihydroergotamine) | Recent Studies (post-2010) (dihydroergotamine) |
|---|---|---|---|---|---|
| 140 | 8 | 22 | 1,450 | 241 | 116 |
| Protein | Taxonomy | raubasine (IC50) | dihydroergotamine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.09 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 3.9996 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.001 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.0089 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0039 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.01 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0007 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 2.395 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.029 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.008 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.09 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0007 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0053 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0068 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.0032 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heidrich, H | 1 |
| Dietzel, M; Grünberger, J; Lesch, OM; Musalek, M; Saletu, B; Schjerve, M; Walter, H; Werner, U; Zeiler, K | 1 |
| Cavalca, L; Ghirardi, P; Ligresti, A; Marchetti, G; Marzo, A; Merlo, L; Omboni, E; Parenti, MA; Pignataro, T | 1 |
1 trial(s) available for raubasine and dihydroergotamine
| Article | Year |
|---|---|
[Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
Topics: Arterial Occlusive Diseases; Cardiovascular Agents; Cinnarizine; Clinical Trials as Topic; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Exercise Test; Flunarizine; Humans; Intermittent Claudication; Nafronyl; Pentoxifylline; Placebos; Pyrrolidines; Secologanin Tryptamine Alkaloids; Yohimbine | 1985 |
2 other study(ies) available for raubasine and dihydroergotamine
| Article | Year |
|---|---|
[Therapy of organic psychosyndromes of cerebrovascular origin with a vasoactive drug combination].
Topics: Adult; Aged; Cerebrovascular Disorders; Dihydroergotamine; Dihydroergotoxine; Drug Combinations; Humans; Middle Aged; Neurocognitive Disorders; Psychological Tests; Secologanin Tryptamine Alkaloids; Self-Assessment; Yohimbine | 1985 |
Pharmacokinetics of a combination of raubasine, dihydroergocristine and dihydroergotamine in dogs and human beings.
Topics: Animals; Bile; Dihydroergotamine; Dihydroergotoxine; Dogs; Drug Combinations; Humans; Isomerism; Kinetics; Protein Binding; Secologanin Tryptamine Alkaloids; Tissue Distribution; Yohimbine | 1981 |